HSANZ and ALLG Welcome the House of Representatives’ Standing Committee Report tabled in Parliament 25 November 2021
The ALLG and HSANZ welcomes the Report tabled in Parliament 25/11/21 on ‘The New Frontier - Delivering better health for all Australians: Inquiry into approval processes for new drugs and novel medical technologies in Australia’, by the House of Representatives Standing Committee on Health, Aged Care and Sport.
Medical innovation has grown exponentially in recent years. The approval processes for new medicines are very complex, and this report discusses different ways to streamline them to provide better and faster patient access to treatments; without compromising on patient safety, efficacy or cost effectiveness.
The Committee’s Report details 31 recommendations which aim to help government improve and reform the regulatory and reimbursement system; and helps pave the way for the improvements needed to provide Australians with the best possible health care now and into the future.
To read the full ALLG and HSANZ statement, click here
This article, co-authored by Steven Lane in The Hematologist provides a summary of the recent literature regarding COVID Vaccination responses in patients with blood cancers. This might be of use when providing information to patients about their options to prevent COVID19 infection.
Click here for the link
Dear Colleagues, re: The ATAGI recommendation for COVID Vaccination in immunocompromised patients
This is an important recommendation from ATAGI and is relevant to many patients with haematological disorders who may have reduced response to standard COVID vaccination regimens.
Steven Lane, President HSANZ
Click here for document
HSANZ Council was pleased to award the Albert Baikie Medal and Award for 2021 to Salvatore (Sam) Fiorenza at Blood2021. Congratulations Sam
Blood2021 on-demand Registration HSANZ sponsorships
With the completion of the live component of the Virtual Blood 2021, HSANZ would like to extend our appreciation to all members who contributed, participated and attended this meeting. The on-demand viewing for all presentations during Blood 2021 will be available for 6 months, as above.
We do realise that a proportion of our haematology constituents were not able to attend live, and therefore announce that HSANZ is offering on-demand registration sponsorship to a select number (maximum 10) of Haematology Advanced Trainees across all states who meet the following eligibility criteria:
1. You must be an active trainee member of HSANZ or have an HSANZ trainee membership submission pending approval to qualify (you must have submitted a signed application form and CV)
Applications close: 31 October 2021.
Please apply by emailing documentation to email
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The tenth webinar in this series features Professor Mohamad Mohty, who is the head of the Haematology and Cellular Therapy Department at the Saint-Antoine Hospital and the head of the translation research team at the Saint-Antoine Research Centre in Paris. He is the past president of the European Society for Blood and Marrow Transplantation (EBMT) and the current chairman of the Acute Leukaemia Working Party of the EBMT. He has published over 800 peer-reviewed articles in the field of stem cell transplantation, leukaemia and myeloma. In this webinar, Prof Mohty will be outlining the role of maintenance therapeutics following allogeneic HSCT for acute leukaemia.
Professor Mohamad Mohty – Saint-Antoine Hospital and Sorbonne University
When: Monday 11 October 2021, 5pm AEDT
For more information click here
Link to webinar:
Link to CBTCT website for all webinar recordings:
The Baker Department of Cardiometabolic Health is hosting a VITT webinar between 4-5:20pm (AEST ) this Thursday, 9 Sept. Speakers include Andreas Greinacher and James McFadyen, with Kanta Subbarao, Huyen Tran and Liz Gardiner joining a panel discussion. Registration is free here
For more information click here
NOTICE OF ANNUAL GENERAL METING 2021
NOTICE IS HEREBY GIVEN THAT THE ANNUAL GENERAL METING OF THE HAEMATOLOGY SOCIETY OF AUSTRALIA AND NEW ZEALAND WILL BE HELD ON WEDNESDAY 22 SEPTEMBER VIA ZOOM
COMMENCING AT 4.00PM AEST
FINANCIAL MEMBERS ONLY CAN VOTE
MEMBERS CAN REGISTER HERE
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The ninth webinar in this series features Professor Catherine Bollard, who is the current Program Director for Cell Enhancement and Technologies at the Children’s National Hospital and Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine at the George Washington University. Her bench and translational research has focused on improving post-transplant outcomes through developing novel cellular therapeutics, leading to over 200 peer reviewed publications. In this webinar, Professor Bollard will be outlining the role of virus-specific T cell therapies following transplantation as well as their potential applications for treating COVID-19.
Professor Catherine Bollard – Children’s National Hospital and George Washington University
When: Monday 27 September 2021, 8am AEST
Link to webinar:
Each year in September, around the world, it is Blood Cancer Awareness Month. A time to focus our attention on blood cancers, to raise awareness of their impact and to advocate for the acceleration of treatments and cures. This September, Snowdome is beginning the month with our educational Blood, Sweat and Tears of Joy event. Once again, we will be going virtual and our 2021 webinar will focus on the developments being made with chimeric antigen receptor T-cell (CAR T-cell) therapy and the role clinical trials can play in the treatment journey. Join us as we provide you with an opportunity to learn from a driven blood cancer clinical researcher and hear first-hand from three inspiring blood cancer patients.
Hosted by Snowdome’s own and HSANZ Member Professor Miles Prince AM, he will be joined on the panel by:
Time: 6:00pm – 7:30pm
Location: Online via zoom
RSVP: Register here
Zoom details will be sent to you upon registration.
Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114
Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.